A unique multi-synaptic mechanism involving acetylcholine and GABA regulates dopamine release in the nucleus accumbens through early adolescence in male rats

  1. Melody C Iacino
  2. Taylor A Stowe
  3. Elizabeth G Pitts
  4. Lacey L Sexton
  5. Shannon L Macauley
  6. Mark J Ferris  Is a corresponding author
  1. Wake Forest University, United States
  2. University of Kentucky, United States

Abstract

Adolescence is characterized by changes in reward-related behaviors, social behaviors, and decision making. These behavioral changes are necessary for the transition into adulthood, but they also increase vulnerability to the development of a range of psychiatric disorders. Major reorganization of the dopamine system during adolescence is thought to underlie, in part, the associated behavioral changes and increased vulnerability. Here, we utilized fast scan cyclic voltammetry and microdialysis to examine differences in dopamine release as well as mechanisms that underlie differential dopamine signaling in the nucleus accumbens (NAc) core of adolescent (P28-35) and adult (P70-90) male rats. We show baseline differences between adult and adolescent stimulated dopamine release in male rats, as well as opposite effects of the a6 nicotinic acetylcholine receptor (nAChR) on modulating dopamine release. The a6-selective blocker, a-conotoxin, increased dopamine release in early adolescent rats, but decreased dopamine release in rats beginning in middle adolescence and extending through adulthood. Strikingly, blockade of GABAA and GABAB receptors revealed that this a6-mediated increase in adolescent dopamine release requires NAc GABA signaling to occur. We confirm the role of a6 nAChR and GABA in mediating this effect in vivo using microdialysis. Results herein suggest a multisynaptic mechanism potentially unique to the period of development that includes early adolescence, involving acetylcholine acting at a6-containing nAChRs to drive inhibitory GABA tone on dopamine release.

Data availability

All data generated or analyzed for this study are available at Harvard dataverse (https://dataverse.harvard.edu/) under the title eLife_2024_Iacino_Ferris, or through the following link:https://doi.org/10.7910/DVN/8D2FJ0

The following data sets were generated
    1. Ferris MJ
    2. et al
    (2024) eLife_2024_Iacino_Ferris
    Harvard Dataverse https://doi.org/10.7910/DVN/8D2FJ0.

Article and author information

Author details

  1. Melody C Iacino

    Department of Translational Neuroscience, Wake Forest University, Winston-Salem, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Taylor A Stowe

    Department of Translational Neuroscience, Wake Forest University, Winston-Salem, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Elizabeth G Pitts

    Department of Translational Neuroscience, Wake Forest University, Winston-Salem, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Lacey L Sexton

    Department of Translational Neuroscience, Wake Forest University, Winston-Salem, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Shannon L Macauley

    Department of Physiology, University of Kentucky, Lexington, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Mark J Ferris

    Department of Translational Neuroscience, Wake Forest University, Winston-Salem, United States
    For correspondence
    mferris@wakehealth.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0127-7955

Funding

National Institute on Drug Abuse (DA031791)

  • Mark J Ferris

National Institute on Drug Abuse (DA006634)

  • Mark J Ferris

National Institute on Alcohol Abuse and Alcoholism (AA026117)

  • Mark J Ferris

National Institute on Alcohol Abuse and Alcoholism (AA028162)

  • Elizabeth G Pitts

National Institute of General Medical Sciences (GM102773)

  • Elizabeth G Pitts

Peter McManus Charitable Trust

  • Mark J Ferris

National Institute on Drug Abuse (DA058517)

  • Melody C Iacino

National Institute on Drug Abuse (DA052460)

  • Mark J Ferris

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Michael A Taffe, University of California, San Diego, United States

Ethics

Animal experimentation: All animals were maintained according to the National Institutes of Health guidelines in Association for Assessment and Accreditation of Laboratory Animal Care accredited facilities (Accreditation #: 00008; PHS Assurance #: D16-00248 (A3391-01)). All experimental protocols were approved by the Institutional Animal Care and Use Committee at Wake Forest School of Medicine (Protocol Approval #: A21-143).

Version history

  1. Received: September 10, 2020
  2. Accepted: June 10, 2024
  3. Accepted Manuscript published: June 11, 2024 (version 1)

Copyright

© 2024, Iacino et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 297
    views
  • 74
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Melody C Iacino
  2. Taylor A Stowe
  3. Elizabeth G Pitts
  4. Lacey L Sexton
  5. Shannon L Macauley
  6. Mark J Ferris
(2024)
A unique multi-synaptic mechanism involving acetylcholine and GABA regulates dopamine release in the nucleus accumbens through early adolescence in male rats
eLife 13:e62999.
https://doi.org/10.7554/eLife.62999

Share this article

https://doi.org/10.7554/eLife.62999

Further reading

    1. Developmental Biology
    Zhimin Xu, Zhao Wang ... Yingchuan B Qi
    Research Article

    Precise developmental timing control is essential for organism formation and function, but its mechanisms are unclear. In C. elegans, the microRNA lin-4 critically regulates developmental timing by post-transcriptionally downregulating the larval-stage-fate controller LIN-14. However, the mechanisms triggering the activation of lin-4 expression toward the end of the first larval stage remain unknown. We demonstrate that the transmembrane transcription factor MYRF-1 is necessary for lin-4 activation. MYRF-1 is initially localized on the cell membrane, and its increased cleavage and nuclear accumulation coincide with lin-4 expression timing. MYRF-1 regulates lin-4 expression cell-autonomously and hyperactive MYRF-1 can prematurely drive lin-4 expression in embryos and young first-stage larvae. The tandem lin-4 promoter DNA recruits MYRF-1GFP to form visible loci in the nucleus, suggesting that MYRF-1 directly binds to the lin-4 promoter. Our findings identify a crucial link in understanding developmental timing regulation and establish MYRF-1 as a key regulator of lin-4 expression.

    1. Developmental Biology
    2. Structural Biology and Molecular Biophysics
    Samuel C Griffiths, Jia Tan ... Hsin-Yi Henry Ho
    Research Article Updated

    The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.